Pure Global AI
NCT06064032Not yet recruiting

Cognitive Behavioral Therapy And Motor Learning Technique Among Attention Deficit Hyperactivity Disorder Adults

Comparing The Effects Of Cognitive Behavioral Therapy And Motor Learning Technique in Adults With Attention Deficit Hyperactivity Disorder.
Shalamar Institute of Health SciencesClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Attention Deficit Hyperactivity Disorder
Drug/Device/Intervention
cognitive behavioral therapy
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Shalamar Institute of Health Sciences
Timeline & enrollment
Phase
N/A
Start date
Oct 02, 2023
End date
Dec 30, 2023
Enrollment
36 participants
Primary outcome

Comparing the Effect of Cognitive Behavioral Therapy and Motor Learning Techniques in Adults with Attention Deficit Hyperactivity Disorder.

Summary

The aim of our study to compare the effect of cognitive behavioral therapy and motor learning
 techniques in adults with Attention Deficit Hyperactivity Disorder. and help the adults to
 address and revise cognitive distortions and habits affecting your productivity and emotional
 mindset.participant allocated to control group will be asked to perform cognitive behavioural
 therapy and participants allocated to experimental group will be asked to perform motor
 learning activities and cognitive behavioral therapy.

ICD-10 classifications
Neurotic disorder, unspecifiedHyperkinetic disorder, unspecifiedHabit and impulse disorder, unspecifiedMild cognitive disorderDisturbance of activity and attention
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06064032
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06064032 through Pure Global AI's free database. This phase not specified trial is sponsored by Shalamar Institute of Health Sciences and is currently Not yet recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 36 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.